Hong Cai

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Incremental Prognostic Value of Pericardial Adipose Tissue Radiomic Phenotype Based on Cardiac MRI in Patients With End-Stage Renal Disease.

Incremental Prognostic Value of Pericardial Adipose Tissue Radiomic Phenotype Based on Cardiac MRI in Patients With End-Stage Renal Disease.

Journal: Journal of magnetic resonance imaging : JMRI

Published: August 02, 2025

The m7G methyltransferase METTL1 promotes acute kidney inflammation by disrupting mitochondrial function.

The m7G methyltransferase METTL1 promotes acute kidney inflammation by disrupting mitochondrial function.

Journal: Kidney international

Published: May 26, 2025

Predicting Adverse Outcomes in Kidney Transplant Recipients Using an Interpretable Model Based on Shear-Wave Elastography.

Predicting Adverse Outcomes in Kidney Transplant Recipients Using an Interpretable Model Based on Shear-Wave Elastography.

Journal: Kidney diseases (Basel, Switzerland)

Published: November 25, 2024

Podocyte Pathogenic Bone Morphogenetic Protein-2 Pathway and Immune Cell Behaviors in Primary Membranous Nephropathy.

Podocyte Pathogenic Bone Morphogenetic Protein-2 Pathway and Immune Cell Behaviors in Primary Membranous Nephropathy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 19, 2024

Metabolic Risk Profile and Graft Function Deterioration 2 Years After Kidney Transplant.

Metabolic Risk Profile and Graft Function Deterioration 2 Years After Kidney Transplant.

Journal: JAMA network open

Published: December 27, 2023

DDRGK1-mediated ER-phagy attenuates acute kidney injury through ER-stress and apoptosis.

DDRGK1-mediated ER-phagy attenuates acute kidney injury through ER-stress and apoptosis.

Journal: Cell death & disease

Published: September 13, 2023

SGLT2i: Therapeutic options or contributing factors of contrast-induced acute kidney injury in the setting of non-diabetes?

SGLT2i: Therapeutic options or contributing factors of contrast-induced acute kidney injury in the setting of non-diabetes?

Journal: Pharmacological research

Published: May 25, 2023

Paxlovid for hospitalized COVID-19 patients with chronic kidney disease.

Paxlovid for hospitalized COVID-19 patients with chronic kidney disease.

Journal: Antiviral research

Published: April 03, 2023

Nirmatrelvir/Ritonavir for hemodialysis patients with COVID-19.

Nirmatrelvir/Ritonavir for hemodialysis patients with COVID-19.

Journal: Frontiers in pharmacology

Published: February 08, 2023

Nirmatrelvir/ritonavir for patients with SARS-CoV-2 infection and impaired kidney function during the Omicron surge.

Nirmatrelvir/ritonavir for patients with SARS-CoV-2 infection and impaired kidney function during the Omicron surge.

Journal: Frontiers in pharmacology

Published: January 19, 2023

Adaptive immune dysfunction in patients with COVID-19 and impaired kidney function during the omicron surge.

Adaptive immune dysfunction in patients with COVID-19 and impaired kidney function during the omicron surge.

Journal: Clinical immunology (Orlando, Fla.)

Published: December 14, 2022

Mitophagy alleviates cisplatin-induced renal tubular epithelial cell ferroptosis through ROS/HO-1/GPX4 axis.

Mitophagy alleviates cisplatin-induced renal tubular epithelial cell ferroptosis through ROS/HO-1/GPX4 axis.

Journal: International journal of biological sciences

Published: November 12, 2022

Showing 1-12 of 25

Last Updated: 09/26/2026